(MonsantoStore.corpmerchandise.com)

Monsanto, rivals eye next step after Syngenta deal collapse

Chicago | Reuters –– Monsanto, having ditched an audacious US$46 billion offer for Syngenta, may downshift to a humbler strategy of beefing up its crop protection portfolio through other acquisitions, partnerships and licensing agreements. The deal’s collapse leaves Monsanto, Syngenta and other agrochemical sector companies facing a bleak landscape of plummeting grain prices and farm […] Read more



(Dave Bedard photo)

Canola basis levels seen hanging steady

CNS Canada — Despite a turbulent start to the week for most commodities due to China’s stock market crash, basis levels for canola remain relatively attractive in Manitoba and much of the Prairies, according to an industry watcher. Canola growers have been receiving cash prices of roughly $10.50 in Manitoba and parts of Saskatchewan, said […] Read more

Shanghai, from the Huangpu River near the Oriental Pearl tower. (CIA.gov)

Canola exports to feel pinch of Chinese market crash

CNS Canada — Canada’s canola exports will likely get dragged down by the sea of red ink flowing from Chinese markets, according to an analyst. “It will slow the export market. The whole canola engine has shrunk a little bit. Production will be down about 15 per cent or thereabouts,” said Errol Anderson of ProMarket […] Read more



(Dave Bedard photo)

StatsCan production estimates ‘too low’ for canola, wheat

CNS Canada — Statistics Canada released its first survey-based production estimates for the 2015-16 crop year Friday morning, with canola and wheat figures coming in at the lower end of expectations. But the grain trade is shrugging off the report, as it believes final production numbers for most crops will be larger than what Statistics […] Read more



(CaseIH.com)

Scientists seek review of glyphosate, allege ‘flawed’ regulations

Reuters — U.S. regulators have relied on flawed and outdated research to allow expanded use of an herbicide linked to cancer, and new assessments should be urgently conducted, according to a column published in the New England Journal of Medicine on Wednesday. There are two key factors that necessitate regulatory action to protect human health, […] Read more